NASDAQ:ALTS - Nasdaq - US47089W1045 - Common Stock - Currency: USD
NASDAQ:ALTS (3/7/2025, 8:04:39 PM)
5.13
-0.15 (-2.84%)
The current stock price of ALTS is 5.13 USD. In the past month the price decreased by -16.18%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
PFE | PFIZER INC | 8.59 | 151.49B | ||
SNY | SANOFI-ADR | 14.24 | 148.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
ZTS | ZOETIS INC | 28.78 | 76.29B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2006-02-22. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.
ALT5 SIGMA CORP
325 E Warm Springs Rd Ste 102
Las Vegas NEVADA US
Employees: 5
Company Website: https://janone.com/
Investor Relations: http://www.arcainc.com/investors/
Phone: 17029975968
The current stock price of ALTS is 5.13 USD. The price decreased by -2.84% in the last trading session.
The exchange symbol of ALT5 SIGMA CORP is ALTS and it is listed on the Nasdaq exchange.
ALTS stock is listed on the Nasdaq exchange.
ALT5 SIGMA CORP (ALTS) has a market capitalization of 72.18M USD. This makes ALTS a Micro Cap stock.
ALT5 SIGMA CORP (ALTS) currently has 5 employees.
ALT5 SIGMA CORP (ALTS) has a support level at 5.12. Check the full technical report for a detailed analysis of ALTS support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALTS does not pay a dividend.
ALT5 SIGMA CORP (ALTS) will report earnings on 2025-04-07.
ALT5 SIGMA CORP (ALTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.92).
The outstanding short interest for ALT5 SIGMA CORP (ALTS) is 1.77% of its float. Check the ownership tab for more information on the ALTS short interest.
ChartMill assigns a technical rating of 4 / 10 to ALTS.
ChartMill assigns a fundamental rating of 1 / 10 to ALTS. ALTS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALTS reported a non-GAAP Earnings per Share(EPS) of -3.92. The EPS decreased by -196.59% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.95% | ||
ROE | -83.81% | ||
Debt/Equity | 0.32 |